What Trump’s reclassification of pot and CBD could mean for seniors, research and stocks

by | Dec 16, 2025 | news, Top News

Reclassification to a Schedule III drug and possible Medicare coverage for pot could unlock new investment from pharmaceutical companies.

Written By

Written by Albert Pham, News Curator and Blogger

Related Posts

0 Comments